Conquest Research, LLC (“Conquest”), a portfolio company of Reynolda Equity Partners (“Reynolda”), has acquired NeuroTrials Research (“NeuroTrials”). Headquartered in Winter Park, FL, Conquest is a clinical trial site network with expertise in neurology, orthopedics, rheumatology, pain, cardiometabolics, internal medicine, and other critical therapeutic areas. Based in Atlanta, GA, NeuroTrials is a multi-specialty focused clinical research center that works with international pharmaceutical and device companies. NeuroTrials has developed clinical expertise across a range of select therapeutic areas with a particular emphasis on neurological diseases including Alzheimer’s Disease and sleep disorders including OSA, insomnia and narcolepsy.
Read the full article: Conquest Research, a Portfolio Company of Reynolda Equity Partners, Acquires NeuroTrials //
Source: https://reynoldaequity.com/wp-content/uploads/2026/01/Conquest-has-acquired-NeuroTrials.pdf